A lawsuit against the FDA charges the agency with failing to respond to a petition to put more stringent warnings on some Parkinson's disease drugs which may increase the risk…
A federal judge indicates parties have reached a global Abilify settlement agreement to resolve thousands of claims that the antipsychotic causes gambling addiction.
Six Abilify gambling addiction lawsuits are being fast-tracked through the discovery process for bellwether trials scheduled to begin next summer.
A federal judge has remanded 21 Abilify gambling lawsuits back to California state courts, while nearly 2,000 cases move forward in the federal litigation.
A number of drugs, including Abilify, Lipitor and Zoloft, were linked to several uncommon, potentially deadly drug side effects in 2017, according to a new report.
Six Abilify lawsuits over compulsive gambling claims have been selected for fast-tracked discovery, in order to prepare for bellwether trials in the spring of 2019.
The discovery process for the second batch of Abilify bellwether trials is moving ahead after a hoped-for settlement agreement failed to occur.
Plaintiffs in Abilify litigation are being asked to submit additional information on their use of the antipsychotic and their gambling addictions.
A pool of 40 Abilify lawsuits have been selected for the second bellwether trial pool, which will eventually be reduced to 10 cases that may go to trial.
A federal judge has ordered the creation of a second bellwether trial pool for Abilify lawsuits filed over compulsive gambling behavior, in case ongoing settlement talks stall or fail.
